Vyne Medical® Acquires Extract Systems® to Enhance Healthcare Automation
Slice of Healthcare Team
09/19/2024
Key Highlights
- Vyne Medical® acquires Extract Systems®, a leader in data extraction solutions.
- Accelerates healthcare automation by integrating AI and machine learning capabilities.
- Reduces data transcription time from 5 minutes to 30 seconds, achieving 90%+ accuracy.
- Enhances clinical workflow and revenue cycle management for hospitals and health systems.
- Expands into government services to improve automation accuracy and support.
Source: Business Wire
Notable Quotes
“ Our acquisition of Extract Systems represents a significant stride in Vyne Medical’s leadership in healthcare automation. ”
Caleb Manscill, President at Vyne Medical
“ We’re thrilled to join forces with Vyne Medical as we march toward our collective goal of making data extraction swift, effortless, and virtually error-free. ”
David Rasmussen, CEO at Extract Systems
SoHC's Take
The acquisition of Extract Systems by Vyne Medical® is a strategic move that significantly enhances healthcare automation at a critical time for the industry. By integrating AI-powered data extraction solutions with Vyne Medical’s workflow tools, the companies are poised to improve operational efficiencies and patient care outcomes. This partnership underscores the growing necessity of automation in healthcare, not just as a competitive advantage but as a fundamental requirement for improving financial performance and the overall care continuum.
Heading
Ginkgo Bioworks Launches Protein LLM and Model API Powered by Google Cloud News Product News Read More Chris-Anne Roque Vyne Medical® Acquires Extract Systems® to Enhance Healthcare Automation News Partnership News Read More Chris-Anne Roque PatientPay Partners with Azalea Health to Streamline Billing for Ambulatory Providers News Partnership News Read More Chris-Anne Roque Raven Health and Flychain Announce Strategic Partnership to Revolutionize Financial Operations for ABA Therapy Providers News Partnership News Read More Chris-Anne Roque Nura Bio Secures $140M in Series A Financing and Appoints Shilpa Sambashivan, Ph.D., as CEO Funding News News Read More Chris-Anne Roque Peer-Reviewed Research Shows CGM Benefits Through Medical Over Pharmacy Clinical News News Read More Chris-Anne Roque
